Jennifer Chadwick, Ph.D.

Dr. Chadwick is Vice President of Analytical Development at ProtaGene. She is an expert in biologics development, with extensive experience in analytical characterization, stability and formulation applied to diverse biologic molecules and systems. For the four years pre-merger, she served as Vice President of Analytical Development and of Biologic Development at BioAnalytix. Previously, Dr. Chadwick was tenured Professor and Louise Byrd Graduate Educator in the Department of Pharmaceutical Chemistry at the University of Kansas. Her academic research focused on understanding molecular mechanisms of underlying instability of proteins and their stabilization by exogenous compounds. During her twelve years at KU, Prof. Chadwick also engaged in biologic drug development and collaborated and consulted with numerous pharma/biotech companies to investigate stability problems and related formulations in therapeutic proteins. She has published approximately 70 peer-reviewed publications, 13 patents and four book chapters, demonstrating her expertise and deep understanding of biologics and drug development. Dr. Chadwick serves as an Associate Director of CASSS and a member of the Steering Committee for academic industry relations at Massachusetts Biotechnology Council. She is also a Visiting Scholar in the Department of Chemistry and Chemical Biology at Northeastern University. She received her Ph.D. from Purdue University, Department of Chemistry.